The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ERIC 2024 | Addressing the inequity in CLL research in Nigeria and other restricted-resource settings
Norah Akinola, MBChB, PhD, Obafemi Awolowo University Teaching Hospitals Complex, Ife, Nigeria, discusses the challenges of managing chronic lymphocytic leukemia (CLL) in Nigeria, particularly the lack of funding and robust research data, which hinders effective advocacy for patients. She emphasizes the need for more clinical trials and advanced diagnostic tools to empower patients and improve their care while also highlighting the importance of patient support groups in navigating their health. This interview took place at the 2024 European Research Initiative on CLL (ERIC) Meeting in Barcelona, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
